Dr. Michael Berman, MD
NPI: 1750497186
Total Payments
$2,944
2021 Payments
$27.18
Companies
7
Transactions
35
Medicare Patients
3,967
Medicare Billing
$136,892
Payment Breakdown by Category
Consulting$1,500 (51.0%)
Food & Beverage$1,444 (49.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,500 | 1 | 51.0% |
| Food and Beverage | $1,444 | 34 | 49.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Foundation Medicine, Inc. | $1,500 | 1 | $0 (2020) |
| Genentech USA, Inc. | $841.30 | 21 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $345.37 | 4 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $166.92 | 5 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $45.53 | 1 | $0 (2018) |
| Roche Diagnostics Corporation | $27.18 | 2 | $0 (2021) |
| Lilly USA, LLC | $17.73 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $27.18 | 2 | Roche Diagnostics Corporation ($27.18) |
| 2020 | $1,518 | 2 | Foundation Medicine, Inc. ($1,500) |
| 2019 | $236.97 | 6 | AstraZeneca Pharmaceuticals LP ($169.55) |
| 2018 | $550.47 | 9 | Genentech USA, Inc. ($389.91) |
| 2017 | $611.68 | 16 | Genentech USA, Inc. ($383.97) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/14/2021 | Roche Diagnostics Corporation | cobas pro ISE analytical unit (Device) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Core Lab | ||||||
| 04/20/2021 | Roche Diagnostics Corporation | Non-Product Specific (Device) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: None | ||||||
| 12/03/2020 | Foundation Medicine, Inc. | FOUNDATIONONE CDX (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: ONCOLOGY | ||||||
| 01/16/2020 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Oncology | ||||||
| 12/19/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $22.49 | General |
| 11/26/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $13.65 | General |
| 11/21/2019 | Genentech USA, Inc. | Rituxan (Biological), GAZYVA, VENCLEXTA | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: BioOncology/Immunology | ||||||
| 09/24/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $83.42 | General |
| Category: Oncology | ||||||
| 09/23/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $86.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/20/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $11.50 | General |
| 10/23/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $45.53 | General |
| 09/27/2018 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $113.56 | General |
| Category: BioOncology | ||||||
| 06/21/2018 | Genentech USA, Inc. | GAZYVA (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: BioOncology | ||||||
| 05/03/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $100.04 | General |
| Category: Oncology | ||||||
| 04/11/2018 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $107.10 | General |
| Category: BioOncology | ||||||
| 03/08/2018 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: BioOncology | ||||||
| 03/01/2018 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: BioOncology | ||||||
| 01/25/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: ONCOLOGY | ||||||
| 01/18/2018 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $122.76 | General |
| Category: BioOncology | ||||||
| 12/07/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $16.50 | General |
| 11/08/2017 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $92.92 | General |
| 10/08/2017 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $75.78 | General |
| Category: Oncology | ||||||
| 08/03/2017 | Genentech USA, Inc. | Herceptin (Biological), Perjeta | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: BioOncology | ||||||
| 06/22/2017 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $119.83 | General |
| 05/11/2017 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 496 | 793 | $71,445 | $16,359 |
| 2022 | 13 | 942 | 1,554 | $147,079 | $35,886 |
| 2021 | 19 | 1,409 | 2,188 | $187,937 | $48,110 |
| 2020 | 18 | 1,120 | 1,630 | $139,153 | $36,536 |
Total Patients
3,967
Total Services
6,165
Medicare Billing
$136,892
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 160 | 339 | $36,599 | $8,015 | 21.9% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 16 | 91 | $7,574 | $1,984 | 26.2% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 47 | 58 | $5,834 | $1,433 | 24.6% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 18 | 19 | $4,533 | $888.30 | 19.6% |
| 86255 | Screening test for antibody to noninfectious agent | Facility | 2023 | 64 | 69 | $3,028 | $803.30 | 26.5% |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | Facility | 2023 | 12 | 15 | $3,039 | $647.72 | 21.3% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 11 | 20 | $2,415 | $614.12 | 25.4% |
| 84165 | Protein measurement, serum | Facility | 2023 | 43 | 46 | $2,072 | $514.79 | 24.8% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Facility | 2023 | 36 | 38 | $2,141 | $470.90 | 22.0% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 37 | 42 | $1,512 | $363.25 | 24.0% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 16 | 18 | $1,444 | $362.09 | 25.1% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 36 | 38 | $1,254 | $262.76 | 21.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 348 | 682 | $73,143 | $17,441 | 23.8% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 46 | 74 | $19,732 | $4,637 | 23.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 29 | 190 | $17,447 | $4,064 | 23.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 108 | 129 | $13,909 | $3,245 | 23.3% |
| 86255 | Screening test for antibody to noninfectious agent | Facility | 2022 | 80 | 85 | $3,060 | $1,197 | 39.1% |
| 84165 | Protein measurement, serum | Facility | 2022 | 57 | 67 | $2,144 | $952.83 | 44.4% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2022 | 84 | 98 | $3,478 | $929.13 | 26.7% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 13 | 29 | $3,737 | $924.63 | 24.7% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2022 | 40 | 47 | $3,731 | $895.51 | 24.0% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Facility | 2022 | 36 | 46 | $3,082 | $662.88 | 21.5% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2022 | 66 | 71 | $2,642 | $592.73 | 22.4% |
| 89060 | Crystal identification from tissue or body fluid | Facility | 2022 | 21 | 22 | $764.00 | $302.72 | 39.6% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2022 | 14 | 14 | $210.00 | $42.19 | 20.1% |
About Dr. Michael Berman, MD
Dr. Michael Berman, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Jefferson Hills, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750497186.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Berman, MD has received a total of $2,944 in payments from pharmaceutical and medical device companies, with $27.18 received in 2021. These payments were reported across 35 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($1,500).
As a Medicare-enrolled provider, Berman has provided services to 3,967 Medicare beneficiaries, totaling 6,165 services with total Medicare billing of $136,892. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Jefferson Hills, PA
- Active Since 08/21/2006
- Last Updated 10/07/2020
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1750497186
Products in Payments
- FOUNDATIONONE CDX (Device) $1,500
- TECENTRIQ (Biological) $437.49
- LYNPARZA (Drug) $183.46
- KEYTRUDA (Biological) $119.19
- IMFINZI (Drug) $86.13
- TAGRISSO (Drug) $75.78
- Herceptin (Biological) $48.26
- Perjeta (Biological) $30.04
- Rituxan (Biological) $19.78
- VENCLEXTA (Biological) $18.17
- VERZENIO (Drug) $17.73
- GAZYVA (Biological) $16.45
- Non-Product Specific (Device) $14.66
- cobas pro ISE analytical unit (Device) $12.52
- Avastin (Biological) $10.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.